Creek Drive Management Group LLC
Position in RNA — Atrium Therapeutics, Inc.
CIK 2111824
SAN FRANCISCO, CA
Position in RNA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,716,220
+$111,820 QoQ
Shares Held
127,600
+6.3% QoQ
Ownership
0.746%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#29
of 155 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in RNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Creek Drive Management Group LLC holds $57,997,020 across 7 Biotechnology names. RNA ranks #4 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
157,500 | $20,988,450 | |
| 2 | NKTR |
Nektar Therapeutics
|
243,000 | $16,963,830 | |
| 3 | QURE |
uniQure N.V.
|
337,000 | $15,522,220 | |
| 4 | RNA |
Atrium Therapeutics, Inc.
This page
|
127,600 | $1,716,220 | |
| 5 | TENX |
Tenax Therapeutics, Inc.
|
74,000 | $1,076,700 | |
| 6 | PALI |
Palisade Bio, Inc.
|
440,000 | $919,600 | |
| 7 | PEPG |
PepGen Inc.
|
450,000 | $810,000 |
All Filings in RNA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,716,220 | 127,600 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,604,400 | 120,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||